Free Trial

Sen. Markwayne Mullin Buys Lam Research Corporation (NASDAQ:LRCX) Stock

Lam Research logo with Computer and Technology background

Senator Markwayne Mullin (R-Oklahoma) recently bought shares of Lam Research Corporation NASDAQ: LRCX. In a filing disclosed on June 11th, the Senator disclosed that they had bought between $15,001 and $50,000 in Lam Research stock on May 13th.

Senator Markwayne Mullin also recently made the following trade(s):

  • Purchased $50,001 - $100,000 in shares of Valero Energy NYSE: VLO on 5/13/2025.
  • Purchased $15,001 - $50,000 in shares of LPL Financial NASDAQ: LPLA on 5/13/2025.
  • Purchased $50,001 - $100,000 in shares of Chevron NYSE: CVX on 5/13/2025.
  • Purchased $50,001 - $100,000 in shares of Zoetis NYSE: ZTS on 5/13/2025.
  • Purchased $15,001 - $50,000 in shares of L3Harris Technologies NYSE: LHX on 5/13/2025.
  • Purchased $15,001 - $50,000 in shares of Adobe NASDAQ: ADBE on 5/13/2025.
  • Purchased $15,001 - $50,000 in shares of CSX NASDAQ: CSX on 5/13/2025.
  • Purchased $15,001 - $50,000 in shares of Texas Instruments NASDAQ: TXN on 5/13/2025.
  • Purchased $15,001 - $50,000 in shares of ConocoPhillips NYSE: COP on 5/13/2025.
  • Purchased $15,001 - $50,000 in shares of Applied Materials NASDAQ: AMAT on 5/13/2025.

Lam Research Trading Down 0.8%

NASDAQ LRCX traded down $0.82 on Friday, hitting $96.96. The company's stock had a trading volume of 8,912,992 shares, compared to its average volume of 8,968,377. The firm has a market cap of $124.02 billion, a P/E ratio of 27.02, a PEG ratio of 1.38 and a beta of 1.68. The company has a current ratio of 2.45, a quick ratio of 1.64 and a debt-to-equity ratio of 0.39. The company's 50-day simple moving average is $92.49 and its 200 day simple moving average is $81.62. Lam Research Corporation has a 52-week low of $56.32 and a 52-week high of $102.59.

Lam Research (NASDAQ:LRCX - Get Free Report) last posted its earnings results on Wednesday, April 23rd. The semiconductor company reported $1.04 EPS for the quarter, topping analysts' consensus estimates of $1.00 by $0.04. Lam Research had a return on equity of 53.21% and a net margin of 27.18%. The business had revenue of $4.72 billion during the quarter, compared to analyst estimates of $4.64 billion. During the same quarter last year, the company earned $7.79 EPS. The company's quarterly revenue was up 24.4% compared to the same quarter last year. Research analysts predict that Lam Research Corporation will post 3.71 EPS for the current fiscal year.

Lam Research Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, July 9th. Shareholders of record on Wednesday, June 18th were issued a $0.23 dividend. This represents a $0.92 annualized dividend and a yield of 0.95%. The ex-dividend date of this dividend was Wednesday, June 18th. Lam Research's dividend payout ratio (DPR) is currently 25.63%.

Analysts Set New Price Targets

Several equities analysts have recently commented on LRCX shares. Deutsche Bank Aktiengesellschaft set a $70.00 price objective on Lam Research and gave the company a "hold" rating in a research report on Thursday, April 24th. The Goldman Sachs Group initiated coverage on Lam Research in a research note on Thursday, July 10th. They set a "buy" rating and a $115.00 price objective on the stock. Morgan Stanley upped their target price on Lam Research from $82.00 to $87.00 and gave the company an "equal weight" rating in a research note on Tuesday, July 1st. Needham & Company LLC dropped their price objective on Lam Research from $96.00 to $80.00 and set a "buy" rating on the stock in a research note on Thursday, April 24th. Finally, Citigroup reiterated a "buy" rating and set a $108.00 price objective (up previously from $87.00) on shares of Lam Research in a report on Monday, July 7th. Seven equities research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $100.57.

Check Out Our Latest Stock Analysis on LRCX

Hedge Funds Weigh In On Lam Research

A number of hedge funds have recently made changes to their positions in LRCX. Community Bank N.A. increased its stake in Lam Research by 4.6% during the 2nd quarter. Community Bank N.A. now owns 32,873 shares of the semiconductor company's stock worth $3,200,000 after buying an additional 1,442 shares during the period. Verdence Capital Advisors LLC grew its position in shares of Lam Research by 2.3% during the 2nd quarter. Verdence Capital Advisors LLC now owns 10,887 shares of the semiconductor company's stock valued at $1,060,000 after buying an additional 245 shares during the last quarter. Envestnet Portfolio Solutions Inc. grew its position in shares of Lam Research by 0.9% during the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 154,694 shares of the semiconductor company's stock valued at $15,058,000 after buying an additional 1,339 shares during the last quarter. Concord Asset Management LLC VA grew its position in shares of Lam Research by 11.3% during the 2nd quarter. Concord Asset Management LLC VA now owns 17,502 shares of the semiconductor company's stock valued at $1,704,000 after buying an additional 1,779 shares during the last quarter. Finally, Vest Financial LLC boosted its stake in Lam Research by 93.5% during the 2nd quarter. Vest Financial LLC now owns 277,326 shares of the semiconductor company's stock valued at $26,995,000 after purchasing an additional 133,993 shares during the period. Institutional investors and hedge funds own 84.61% of the company's stock.

About Senator Mullin

Markwayne Mullin (Republican Party) is a member of the U.S. Senate from Oklahoma. He assumed office on January 11, 2023. His current term ends on January 3, 2027. Mullin (Republican Party) ran in a special election to the U.S. Senate to represent Oklahoma. He won in the special general election on November 8, 2022. Mullin is a member of the Cherokee Nation and one of four Native American members of the 116th Congress. At the age of 20, Mullin took over his father's plumbing business. He is also a former professional mixed martial artist. Markwayne Mullin graduated from Stilwell High School. Mullin earned an associate degree in construction technology from Oklahoma State University Institute of Technology. His career experience includes owning and founding multiple businesses.

About Lam Research

(Get Free Report)

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

Further Reading

Should You Invest $1,000 in Lam Research Right Now?

Before you consider Lam Research, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.

While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines